Sosei buys Idorsia Pharmaceuticals' Japan, Korea units for $466 million - Nikkei

Nxera Pharma

20/07/2023 07:23

TOKYO, July 20 (Reuters) - Japanese biopharma Sosei
Group  4565.T  has bought Swiss-based Idorsia Pharmaceuticals'
 IDIA.S  businesses in Japan and South Korea for about 65
billion yen ($466.08 million), the Nikkei newspaper reported on
Thursday.
    Sosei, in its largest-ever acquisition deal, has also bought
some milestone rights to develop and sell drugs from Idorsia,
Nikkei said.

($1 = 139.4600 yen)

 (Reporting by Kantaro Komiya; Editing by Kim Coghill)
 ((Kantaro.Komiya@thomsonreuters.com; Twitter: @kantarokomiya;))